Circulating Betatrophin Concentrations Are Decreased in Human Obesity and Type 2 Diabetes

Abstract

We conclude that serum betatrophin is decreased in human obesity, being further reduced in obesity-associated insulin resistance. Betatrophin levels are closely related to obesity-associated cardiometabolic risk factors, emerging as a potential biomarker of insulin resistance and T2D.